Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Microarray data from simple and effective differentiation-switching model using long-term-expanded mammary primary cells

ABSTRACT: We developed a long-term expansion method for primary mammary basal cells using a set of compounds. Moreover, we established a simple and effective epithelial differentiation method by simply removing the compounds. As a benefit of this convenient differentiation-switching technique, we obtained microarray data comparing each differentiation state and confirmed that the transcription factors EGR1 and ELF3 determine mammary differentiation states at the cellular level. This culturing method is an effective tool for verifying molecular mechanisms that determine mammary differentiation state and can be useful in future epithelial cell biology, physiology, and regeneration research.

ORGANISM(S): Homo sapiens

PROVIDER: GSE254887 | GEO | 2025/04/16

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Microarray data from simple and effective differentiation-switching model using long-term-expanded prostate primary cells

Project description:We developed a long-term expansion method for primary prostate cells using a set of compounds. Moreover, we established a simple and effective epithelial differentiation method by simply removing the compounds. As a benefit of this convenient differentiation-switching technique, we obtained microarray data comparing each differentiation state and confirmed many genes that determine differentiation states at the cellular level. This culturing method can be useful in future epithelial cell biology, physiology, and regeneration research.

2025-04-16 | GSE283321 | GEO

Microarray data from simple and effective differentiation-switching model using long-term-expanded mammary primary cells

Project description:Microarray data from simple and effective differentiation-switching model using long-term-expanded mammary primary cells

| PRJNA1072144 | ENA

Expression profiling analysis of an inducible ELF3-expressing and control human bile duct cells [inducible ELF3]

Project description:An immortalized normal epithelial cell line of common bile duct origin (HBDEC2 cells) was established. An inducible ELF3-expressing was generated by infection with the retrovial vector pRetroX-TetOne-Puro-ELF3-flag, expressing ELF3 fused to a flag-tag.

2020-08-27 | GSE148107 | GEO

DNA methylation profiling of lung adenocarcinomas and patient-matched non-malignant lung

Project description:Gene function in cancer is often cell type-specific. The epithelial cell-specific transcription factor ELF3 is a documented tumour suppressor in many epithelial tumours yet displays oncogenic properties in others. Here, we show that ELF3 is an oncogene in the adenocarcinoma subtype of lung cancer (LUAD), providing genetic, functional, and clinical evidence of subtype specificity. We discover a region of focal amplification at chromosome 1q32.1 encompassing the ELF3 locus in LUAD which is absent in the squamous subtype. Gene dosage and promoter hypomethylation affect the locus in up to 80% of LUAD analysed. ELF3 expression was required for tumour growth and a pan-cancer expression network analysis supports its subtype and tissue specificity. We further show that ELF3 displays strong prognostic value in LUAD but not LUSC. We conclude that, contrary to many other tumours of epithelial origin, ELF3 is an oncogene and putative therapeutic target in LUAD.

2019-10-23 | GSE139032 | GEO

Expression profiling of isogenic A549 cell lines with and without ELF3 knock-down

2019-10-23 | GSE137479 | GEO

Comparison of mouse epithelial tumor initiating cells to mesenchymal tumor initiating cells generated by EMT

Project description:The differentiation of stem-like cells of tumors may contribute to the cellular heterogeneity of breast cancers. We report the propagation of highly enriched mouse mammary cancer stem cells that retain the potential to differentiate both in vivo and in culture and their use to identify chemical compounds that influence both self-renewal and differentiation. We identify epithelial tumor initiating cells (ETIC) that expresses lineage markers of both basal and luminal mammary cell lineages and retains the potential to generate heterogeneous tumors similar to the tumor of origin from even single cells. ETIC can progress through a Rho associated coil-coil protein kinase 1 (ROCK1) dependent, epithelial to mesenchymal transition to generate a second cell type capable of initiating tumors of limited heterogeneity. The propagation of ETIC will increase the opportunities for identifying new therapeutic compounds that may inhibit or prevent progression of some types of breast cancer. These data compare the gene expression pattern of ETIC and MTIC. Total RNA obtained from ETIC and MTIC cells, allowing the comparison of gene expression patterns and the selection of potential targets.

2012-09-01 | E-GEOD-33433 | biostudies-arrayexpress

Transcription profiling of human HMLER breast cancer cells treated with paclitaxel and salinomycin-treated HMLER breast cancer cells

Project description:Screens for agents that specifically kill epithelial cancer stem cells (CSCs) have not been possible due to the rarity of these cells within tumor cell populations and their relative instability in culture. We describe here an approach to screening for agents with epithelial CSC-specific toxicity. We implemented this method in a chemical screen and discovered compounds showing selective toxicity for breast CSCs. One compound, salinomycin, reduces the proportion of CSCs by >100-fold relative to paclitaxel, a commonly used breast cancer chemotherapeutic drug. Treatment of mice with salinomycin inhibits mammary tumor growth in vivo and induces increased epithelial differentiation of tumor cells. In addition, global gene expression analyses show that salinomycin treatment results in the loss of expression of breast CSC genes previously identified by analyses of breast tissues isolated directly from patients. This study demonstrates the ability to identify agents with specific toxicity for epithelial CSCs Experiment Overall Design: Experimentally transformed HMLER breast cancer cells were treated in culture with either paclitaxel (10nM) or salinomycin (1uM) for one week. There were three biologic replicates for each treatment condition.

2009-09-15 | E-GEOD-17215 | biostudies-arrayexpress

Expression data from paclitaxel and salinomycin-treated HMLER breast cancer cells

2009-08-20 | GSE17215 | GEO

Transcriptional gene expression regulation in medullary thymic epithelial cells by the transcription factors Ehf, Fezf2, Elf3 and Klf4

Project description:ChIP sequencing of Ehf, Fezf2, Elf3 and Klf4 was performed on medullary thymic epithelial cells to analyze the role of Ehf-, Fezf2-, Elf3- and Klf4-dependent gene regulation in mTECs.

2024-02-14 | GSE232702 | GEO

DNA copy number profiling of lung adenocarcinomas and patient-matched non-malignant lung

2019-10-23 | GSE139294 | GEO